Hepatoprotection by malotilate against carbon tetrachloride-alcohol-induced liver fibrosis

16Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Subchronic treatment of male rats with carbon tetrachloride (CCl4, twice weekly 0.2 ml/kg p.o) and feeding a 5% alcohol solution instead of drinking water led to a nearly complete liver cirrhosis in all animals within 4 weeks. This was also documented by a three fold increase in hepatic total hydroxyproline content. Steatosis was quantified by enhanced liver triglyceride concentrations and acute necroses by increments of serum enzyme activities (GPT, SDH). Daily oral treatment with malotilate (100 mg/kg) totally prevented the development of liver cirrhosis, hepatic hydroxyproline accumulation and increases in serum enzyme activities induced by CCl4-alcohol. In cianidanol-treated rats (100 mg/kg p.o.) only portoseptal fibrosis was seen, however hydroxyproline and triglyceride accumulation as well as enhanced serum enzyme activities were not suppressed. D-penicillamine (300 mg/kg p.o.) and colchicine (50 μg/kg i.p.) failed to protect rats against CCl4-alcohol induced fibrosis, necrosis and steatosis in this model. © 1986 Birkhäuser Verlag.

Cite

CITATION STYLE

APA

Siegers, C. P., Pauli, V., Korb, G., & Younes, M. (1986). Hepatoprotection by malotilate against carbon tetrachloride-alcohol-induced liver fibrosis. Agents and Actions, 18(5–6), 600–603. https://doi.org/10.1007/BF01964970

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free